Still, in clinical trials, the weekly pill blocks a protein that helps the virus multiply. As a result, HIV levels in the body drop. It seems to work against some drug-resistant strains of HIV, too.

Novel vaccine concept generates immune responses that could produce multiple types of HIV broadly neutralizing antibodies. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com ...

To date, however, the best antibodies — immune system proteins that fight infections — that researchers have found block only 30 percent to 40 percent of all HIV strains. The identification of ...

HIV-1 is the most common type of HIV, while HIV-2 is less common, with most cases being in West Africa. HIV symptoms are similar to flu symptoms and can include fever, rash, chills, tiredness, and ...

A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated. Developed by researchers from the Massachusetts Institute of Technology (MIT) and ...

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a ...

At least two types of HIV drugs don’t work against the strain, and another type has limited effectiveness, officials from Public Health — Seattle & King County said Thursday.

The researchers note that patients taking other types of HIV medications did not show the same reduction in Alzheimer's risk as those on NRTIs.

In an early-stage study in the journal Nature, researchers said the gene, called MX2, appears to play a key role in how HIV is controlled in human cells, so using it could lead to the development ...